text:
Patent US4865845 - Release rate adjustment of osmotic or diffusional delivery devices - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsA sleeve shaped structure covers a portion of the transport area of a diffusional or osmotic delivery device. The structure is durable and inert to the use environment. Markings on the structure indicate where breaking or cutting will produce a predictable alteration in delivery rate. Among other attachment...http://www.google.com/patents/US4865845?utm_source=gb-gplus-sharePatent US4865845 - Release rate adjustment of osmotic or diffusional delivery devicesAdvanced Patent SearchPublication numberUS4865845 APublication typeGrantApplication numberUS 07/090,720Publication dateSep 12, 1989Filing dateAug 28, 1987Priority dateMar 21, 1986Fee statusPaidPublication number07090720, 090720, US 4865845 A, US 4865845A, US-A-4865845, US4865845 A, US4865845AInventorsJames B. Eckenhoff, John UrquhartOriginal AssigneeAlza CorporationExport CitationBiBTeX, EndNote, RefManPatent Citations (20), Referenced by (245), Classifications (6), Legal Events (4) External Links: USPTO, USPTO Assignment, EspacenetRelease rate adjustment of osmotic or diffusional delivery devices
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3760984 *Sep 29, 1971Sep 25, 1973Alza CorpOsmotically powered agent dispensing device with filling meansUS3845770 *Jun 5, 1972Nov 5, 1974Alza CorpOsmatic dispensing device for releasing beneficial agentUS3916899 *Feb 7, 1974Nov 4, 1975Alza CorpOsmotic dispensing device with maximum and minimum sizes for the passagewayUS3987790 *Oct 1, 1975Oct 26, 1976Alza CorporationOsmotically driven fluid dispenserUS3993058 *Jun 23, 1975Nov 23, 1976Alza CorporationIntrauterine device with seeker for finding the cervical os and housing member for fitting device in an inserterUS3993073 *Mar 3, 1975Nov 23, 1976Alza CorporationNovel drug delivery deviceUS3995631 *Sep 25, 1972Dec 7, 1976Alza CorporationOsmotic dispenser with means for dispensing active agent responsive to osmotic gradientUS4016880 *Mar 4, 1976Apr 12, 1977Alza CorporationOsmotically driven active agent dispenserUS4111202 *Nov 22, 1976Sep 5, 1978Alza CorporationOsmotic system for the controlled and delivery of agent over timeUS4111203 *Nov 22, 1976Sep 5, 1978Alza CorporationOsmotic system with means for improving delivery kinetics of systemUS4203440 *Oct 23, 1978May 20, 1980Alza CorporationDevice having variable volume chamber for dispensing useful agentUS4203442 *Jan 4, 1979May 20, 1980Alza CorporationDevice for delivering drug to a fluid environmentUS4210139 *Jan 17, 1979Jul 1, 1980Alza CorporationOsmotic device with compartment for governing concentration of agent dispensed from deviceUS4300558 *Jul 18, 1980Nov 17, 1981Alza CorporationSelf-driven fluid dispenserUS4304232 *Jan 28, 1980Dec 8, 1981Alza CorporationUnit system having multiplicity of means for dispensing useful agentUS4320758 *Dec 8, 1980Mar 23, 1982Alza CorporationOsmotically driven fluid dispenserUS4327725 *Nov 25, 1980May 4, 1982Alza CorporationOsmotic device with hydrogel driving memberUS4350271 *Aug 22, 1980Sep 21, 1982Alza CorporationWater absorbing fluid dispenserUS4367741 *Dec 22, 1980Jan 11, 1983Alza CorporationDispenser powered by cross-linked hydrophilic polymer grafted to hydrophilic polymerUS4474575 *Sep 22, 1982Oct 2, 1984Alza CorporationSelf-driven pump assembly and method of operation* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS4969872 *Mar 8, 1989Nov 13, 1990Alza CorporationIntravenous system for delivering a beneficial agent with delivery rate control via permeable surface area varianceUS5201728 *May 3, 1991Apr 13, 1993Giampapa Vincent CSubcutaneous implantable multiple-agent delivery systemUS5312389 *Apr 3, 1992May 17, 1994Felix TheeuwesOsmotically driven syringe with programmable agent deliveryUS5370635 *Sep 30, 1993Dec 6, 1994Asulab S.A.Device for delivering a medicamentUS5728396 *Jan 30, 1997Mar 17, 1998Alza CorporationSustained delivery of leuprolide using an implantable systemUS5845633 *Nov 22, 1996Dec 8, 1998Siemens Elema A.B.Dosing device for adding a controlled amount of a gas to a fluidUS5985305 *Oct 2, 1997Nov 16, 1999Alza CorporationSustained delivery of an active agent using an implantable systemUS6113938 *Jul 24, 1998Sep 5, 2000Alza CorporationBeneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agentsUS6132420 *Nov 14, 1997Oct 17, 2000Alza CorporationOsmotic delivery system and method for enhancing start-up and performance of osmotic delivery systemsUS6156331 *May 12, 1999Dec 5, 2000Alza CorporationSustained delivery of an active agent using an implantable systemUS6261584Aug 4, 1999Jul 17, 2001Alza CorporationSustained delivery of an active agent using an implantable systemUS6270787Dec 22, 1998Aug 7, 2001Alza CorporationOsmotic delivery system with membrane plug retention mechanismUS6283953Dec 22, 1998Sep 4, 2001Alza CorporationOsmotic drug delivery monitoring system and methodUS6287295Jul 24, 1998Sep 11, 2001Alza CorporationOsmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systemsUS6375978Dec 17, 1998Apr 23, 2002Alza CorporationRate controlling membranes for controlled drug delivery devicesUS6436091 *Nov 16, 1999Aug 20, 2002Microsolutions, Inc.Methods and implantable devices and systems for long term delivery of a pharmaceutical agentUS6508808Dec 21, 2000Jan 21, 2003Alza CorporationValve for osmotic devicesUS6541021Mar 10, 2000Apr 1, 2003Durect CorporationDevices and methods for pain managementUS6582418 *Jun 1, 2000Jun 24, 2003Medtronic, Inc.Drug pump with reinforcing groovesUS6632217 *Apr 19, 2001Oct 14, 2003Microsolutions, Inc.Implantable osmotic pumpUS6635268Mar 28, 2002Oct 21, 2003Alza CorporationSustained delivery of an active agent using an implantable systemUS6682522Dec 4, 2002Jan 27, 2004Alza CorporationValve for osmotic devicesUS6689373Nov 26, 2002Feb 10, 2004Durect CorporationDevices and methods for pain managementUS6835194Jun 27, 2002Dec 28, 2004Durect CorporationImplantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congenersUS6840931Oct 25, 2002Jan 11, 2005Alza CorporationOsmotic delivery system flow modulator apparatus and methodUS6899887May 17, 2001May 31, 2005Micron Technology, Inc.Osmotic delivery system with membrane plug retention mechanismUS6923800May 18, 2001Aug 2, 2005Alza CorporationOsmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systemsUS6976981May 17, 2001Dec 20, 2005Alza CorporationOsmotic delivery system with membrane plug retention mechanismUS6977074Feb 2, 2001Dec 20, 2005Mannkind CorporationMethod of inducing a CTL responseUS6978174Jul 28, 2004Dec 20, 2005Ardian, Inc.Methods and devices for renal nerve blockingUS6994851Jul 10, 1998Feb 7, 2006Mannkind CorporationMethod of inducing a CTL responseUS7014636Nov 21, 2002Mar 21, 2006Alza CorporationOsmotic delivery device having a two-way valve and a dynamically self-adjusting flow channelUS7162303Apr 8, 2003Jan 9, 2007Ardian, Inc.Renal nerve stimulation method and apparatus for treatment of patientsUS7163688Jun 18, 2002Jan 16, 2007Alza CorporationOsmotic implant with membrane and membrane retention meansUS7207982Mar 31, 2004Apr 24, 2007Alza CorporationOsmotic pump with means for dissipating internal pressureUS7254449Jan 27, 2006Aug 7, 2007Advanced Bionics CorpSystems and methods for providing power to one or more implantable devicesUS7316680Sep 27, 2005Jan 8, 2008Intarcia Therapeutics, Inc.Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channelUS7347746Oct 27, 2006Mar 25, 2008Boston Scientific Neuromodulation CorporationReceptacle connector assemblyUS7364729Dec 19, 2005Apr 29, 2008Mannkind CorporationMethod of inducing a CTL responseUS7368126Nov 4, 2003May 6, 2008Guohua ChenControlled release depot formulationsUS7407500Nov 22, 2004Aug 5, 2008Alza CorporationOsmotic delivery system flow modulator apparatus and methodUS7407973Oct 21, 2004Aug 5, 2008Intermune, Inc.Use of pirfenidone in therapeutic regimensUS7445528Sep 29, 2006Nov 4, 2008Boston Scientific Neuromodulation CorporationConnector assembliesUS7483746Dec 6, 2005Jan 27, 2009Boston Scientific Neuromodulation Corp.Stimulation of the stomach in response to sensed parameters to treat obesityUS7493172Mar 4, 2005Feb 17, 2009Boston Scientific Neuromodulation Corp.Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical conditionUS7610100Dec 30, 2005Oct 27, 2009Boston Scientific Neuromodulation CorporationMethods and systems for treating osteoarthritisUS7617005Aug 14, 2006Nov 10, 2009Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulationUS7620451Feb 27, 2006Nov 17, 2009Ardian, Inc.Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approachUS7647115Jun 3, 2005Jan 12, 2010Ardian, Inc.Renal nerve stimulation method and apparatus for treatment of patientsUS7653438Jan 26, 2010Ardian, Inc.Methods and apparatus for renal neuromodulationUS7655257Aug 20, 2003Feb 2, 2010Intarcia Therapeutics, Inc.Sustained delivery of an active agent using an implantable systemUS7684858Sep 21, 2005Mar 23, 2010Boston Scientific Neuromodulation CorporationMethods and systems for placing an implanted stimulator for stimulating tissueUS7717948Aug 16, 2007May 18, 2010Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulationUS7729758Nov 30, 2005Jun 1, 2010Boston Scientific Neuromodulation CorporationMagnetically coupled microstimulatorsUS7769461Dec 17, 2004Aug 3, 2010Boston Scientific Neuromodulation CorporationSkull-mounted electrical stimulation system and method for treating patientsUS7777641Mar 29, 2006Aug 17, 2010Advanced Bionics, LlcSystems and methods of facilitating communication between a first and second deviceUS7799037Feb 11, 2003Sep 21, 2010Boston Scientific Neuromodulation CorporationSurgical insertion toolUS7829109Nov 14, 2002Nov 9, 2010Durect CorporationCatheter injectable depot compositions and uses thereofUS7835803Jan 17, 2007Nov 16, 2010Boston Scientific Neuromodulation CorporationLead assemblies with one or more switching networksUS7848803Mar 26, 2007Dec 7, 2010Boston Scientific Neuromodulation CorporationMethods and systems for facilitating stimulation of one or more stimulation sitesUS7853321Oct 25, 2005Dec 14, 2010Boston Scientific Neuromodulation CorporationStimulation of a stimulation site within the neck or headUS7853333Jun 12, 2006Dec 14, 2010Ardian, Inc.Methods and apparatus for multi-vessel renal neuromodulationUS7896867 *Jul 1, 2005Mar 1, 2011Microlin, LlcFluid delivery device having an electrochemical pump with an ion-exchange membrane and associated methodUS7937143Oct 18, 2005May 3, 2011Ardian, Inc.Methods and apparatus for inducing controlled renal neuromodulationUS7959938Mar 13, 2006Jun 14, 2011Intarcia Therapeutics, Inc.Polyoxaester suspending vehicles for use with implantable delivery systemsUS8080259Dec 29, 2009Dec 20, 2011Intarcia Therapeutics, Inc.Sustained delivery of an active agent using an implantable systemUS8095219Jan 23, 2009Jan 10, 2012Boston Scientific Neuromodulation CorporationStimulation of the stomach in response to sensed parameters to treat obesityUS8114430May 3, 2011Feb 14, 2012Intarcia Therapeutics, Inc.Polyoxaester suspending vehicles for use with implantable delivery systemsUS8114437Feb 3, 2006Feb 14, 2012Intarcia Therapeutics, Inc.Solvent/polymer solutions as suspension vehiclesUS8131371Apr 13, 2006Mar 6, 2012Ardian, Inc.Methods and apparatus for monopolar renal neuromodulationUS8131372Mar 19, 2007Mar 6, 2012Ardian, Inc.Renal nerve stimulation method for treatment of patientsUS8145316Jul 25, 2005Mar 27, 2012Ardian, Inc.Methods and apparatus for renal neuromodulationUS8145317Mar 6, 2006Mar 27, 2012Ardian, Inc.Methods for renal neuromodulationUS8150518Jun 3, 2005Apr 3, 2012Ardian, Inc.Renal nerve stimulation method and apparatus for treatment of patientsUS8150519Mar 6, 2006Apr 3, 2012Ardian, Inc.Methods and apparatus for bilateral renal neuromodulationUS8150520Mar 6, 2006Apr 3, 2012Ardian, Inc.Methods for catheter-based renal denervationUS8175710Mar 14, 2006May 8, 2012Boston Scientific Neuromodulation CorporationStimulator system with electrode array and the method of making the sameUS8175711Mar 6, 2006May 8, 2012Ardian, Inc.Methods for treating a condition or disease associated with cardio-renal functionUS8206745Jun 10, 2011Jun 26, 2012Intarcia Therapeutics, Inc.Solvent/polymer solutions as suspension vehiclesUS8211467Nov 1, 2010Jul 3, 2012Intarcia Therapeutics, Inc.Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehiclesUS8214058Oct 12, 2010Jul 3, 2012Boston Scientific Neuromodulation CorporationLead assemblies with one or more switching networksUS8224451Nov 17, 2010Jul 17, 2012Boston Scientific Neuromodulation CorporationMethods and systems for facilitating stimulation of one or more stimulation sitesUS8252303Nov 14, 2002Aug 28, 2012Durect CorporationInjectable depot compositions and uses thereofUS8278330Sep 27, 2010Oct 2, 2012Durect CorporationShort duration depot formulationsUS8298562May 26, 2011Oct 30, 2012Intarcia Therapeutics, Inc.Sustained delivery of an active agent using an implantable systemUS8315704Nov 5, 2010Nov 20, 2012Boston Scientific Neuromodulation CorporationStimulation of a stimulation site within the neck or headUS8347891Nov 14, 2006Jan 8, 2013Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumenUS8364280Jul 21, 2009Jan 29, 2013Boston Scientific Neuromodulation CorporationEngagement tool for implantable medical devicesUS8372393May 3, 2006Feb 12, 2013Mannkind CorporationMethod of inducing a CTL responseUS8401654Jun 30, 2006Mar 19, 2013Boston Scientific Neuromodulation CorporationMethods and systems for treating one or more effects of deafferentationUS8404653Nov 13, 2006Mar 26, 2013Enterprise Partners Venture CapitalMembrane bound stem cell factor therapy for ischemic heartUS8423154Jun 12, 2012Apr 16, 2013Boston Scientific Neuromodulation CorporationLead assemblies with one or more switching networksUS8423155Aug 8, 2008Apr 16, 2013Boston Scientific Neuromodulation CorporationMethods and systems for facilitating stimulation of one or more stimulation sitesUS8433423Dec 13, 2010Apr 30, 2013Ardian, Inc.Methods for multi-vessel renal neuromodulationUS8440226Jun 18, 2012May 14, 2013Intarcia Therapeutics, Inc.Solvent/polymer solutions as suspension vehiclesUS8444640Sep 14, 2012May 21, 2013Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumenUS8452407Jul 29, 2005May 28, 2013Boston Scientific Neuromodulation CorporationMethods for treating gastrointestinal disordersUS8454594Aug 11, 2009Jun 4, 2013Medtronic Ardian Luxembourg S.A.R.L.Apparatus for performing a non-continuous circumferential treatment of a body lumenUS8460694Jun 11, 2013Intarcia Therapeutics, Inc.Solvent/polymer solutions as suspension vehiclesUS8496943Jul 18, 2005Jul 30, 2013Durect CorporationNon-aqueous single phase vehicles and formulations utilizing such vehiclesUS8501215Jul 28, 2003Aug 6, 2013Guohua ChenInjectable multimodal polymer depot compositions and uses thereofUS8504163Jun 30, 2006Aug 6, 2013Boston Scientific Neuromodulation CorporationCranially mounted stimulation systems and methodsUS8515541Dec 22, 2005Aug 20, 2013Boston Scientific Neuromodulation CorporationMethods and systems for treating post-stroke disordersUS8535701Oct 4, 2012Sep 17, 2013Intarcia Therapeutics, Inc.Sustained delivery of an active agent using an implantable systemUS8548600Sep 14, 2012Oct 1, 2013Medtronic Ardian Luxembourg S.A.R.L.Apparatuses for renal neuromodulation and associated systems and methodsUS8551069Mar 6, 2006Oct 8, 2013Medtronic Adrian Luxembourg S.a.r.l.Methods and apparatus for treating contrast nephropathyUS8620423Mar 14, 2011Dec 31, 2013Medtronic Ardian Luxembourg S.A.R.L.Methods for thermal modulation of nerves contributing to renal functionUS8626300Mar 11, 2011Jan 7, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for thermally-induced renal neuromodulationUS8630705Mar 21, 2011Jan 14, 2014Boston Scientific Neuromodulation CorporationImplantable stimulatorUS8644954Apr 15, 2013Feb 4, 2014Boston Scientific Neuromodulation CorporationMethods and systems for facilitating stimulation of one or more stimulation sitesUS8684998Mar 9, 2012Apr 1, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for inhibiting renal nerve activityUS8721637Jul 12, 2013May 13, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloonsUS8728137Feb 12, 2013May 20, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulationUS8728138Feb 12, 2013May 20, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulationUS8740896Jul 12, 2013Jun 3, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloonsUS8768470May 11, 2010Jul 1, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for monitoring renal neuromodulationUS8771252May 20, 2005Jul 8, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and devices for renal nerve blockingUS8774913Nov 14, 2006Jul 8, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for intravasculary-induced neuromodulationUS8774922May 21, 2013Jul 8, 2014Medtronic Ardian Luxembourg S.A.R.L.Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methodsUS8784463Feb 12, 2013Jul 22, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulationUS8805545Apr 16, 2013Aug 12, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for multi-vessel renal neuromodulationUS8818514Jul 2, 2013Aug 26, 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for intravascularly-induced neuromodulationUS8845629Apr 5, 2010Sep 30, 2014Medtronic Ardian Luxembourg S.A.R.L.Ultrasound apparatuses for thermally-induced renal neuromodulationUS8852163Jun 28, 2013Oct 7, 2014Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methodsUS8880186Apr 11, 2013Nov 4, 2014Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation for treatment of patients with chronic heart failureUS8934978Apr 22, 2014Jan 13, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for renal neuromodulationUS8948865Nov 15, 2013Feb 3, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for treating heart arrhythmiaUS8958871Jan 14, 2011Feb 17, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approachUS8983595Nov 21, 2013Mar 17, 2015Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation for treatment of patients with chronic heart failureUS8986294Feb 4, 2010Mar 24, 2015Medtronic Ardian Luxembourg S.a.rl.Apparatuses for thermally-induced renal neuromodulationUS9023037Apr 23, 2013May 5, 2015Medtronic Ardian Luxembourg S.A.R.L.Balloon catheter apparatus for renal neuromodulationUS9072527Jul 15, 2013Jul 7, 2015Medtronic Ardian Luxembourg S.A.R.L.Apparatuses and methods for renal neuromodulationUS9095553Oct 9, 2012Aug 4, 2015Intarcia Therapeutics Inc.Solvent/polymer solutions as suspension vehiclesUS9095713Jun 30, 2006Aug 4, 2015Allison M. FosterMethods and systems for treating autism by decreasing neural activity within the brainUS9108040Jun 26, 2014Aug 18, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for multi-vessel renal neuromodulationUS9125661Oct 17, 2013Sep 8, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for renal neuromodulationUS9131978Apr 23, 2014Sep 15, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for bilateral renal neuromodulationUS9138281Sep 23, 2013Sep 22, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for bilateral renal neuromodulation via catheter apparatuses having expandable basketsUS9186198Sep 14, 2012Nov 17, 2015Medtronic Ardian Luxembourg S.A.R.L.Ultrasound apparatuses for thermally-induced renal neuromodulation and associated systems and methodsUS9186213May 15, 2014Nov 17, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for renal neuromodulationUS9192715Mar 21, 2014Nov 24, 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for renal nerve blockingUS20010027311 *May 18, 2001Oct 4, 2001Guohua ChenOsmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systemsUS20020007173 *Feb 2, 2001Jan 17, 2002Kundig Thomas M.Method of inducing a CTL responseUS20020034532 *Nov 25, 2001Mar 21, 2002Brodbeck Kevin J.Injectable depot gel composition and method of preparing the compositionUS20030044467 *Aug 19, 2002Mar 6, 2003Brodbeck Kevin J.Gel composition and methodsUS20030083647 *Nov 27, 2002May 1, 2003Pamela FereiraOsmotic beneficial agent delivery systemUS20030108590 *Jun 18, 2002Jun 12, 2003Peery John R.Osmotic implant with membrane and membrane retention meansUS20030114837 *Oct 25, 2002Jun 19, 2003Peterson Lewis L.Osmotic delivery system flow modulator apparatus and methodUS20030135202 *Jan 17, 2003Jul 17, 2003Microsolutions, Inc.Implantable osmotic pumpUS20030157178 *Nov 14, 2002Aug 21, 2003Guohua ChenInjectable depot compositionUS20030170289 *Nov 14, 2002Sep 11, 2003Guohua ChenInjectable depot compositions and uses thereofUS20030180364 *Nov 14, 2002Sep 25, 2003Guohua ChenCatheter injectable depot compositions and uses thereofUS20030211974 *Jun 4, 2003Nov 13, 2003Brodbeck Kevin J.Gel composition and methodsUS20040001889 *Jun 25, 2003Jan 1, 2004Guohua ChenShort duration depot formulationsUS20040022859 *Jul 28, 2003Feb 5, 2004Guohua ChenInjectable multimodal polymer depot compositions and uses thereofUS20040024069 *Nov 14, 2002Feb 5, 2004Guohua ChenInjectable depot compositions and uses thereofUS20040039376 *Aug 20, 2003Feb 26, 2004Peery John R.Sustained delivery of an active agent using an implantable systemUS20040102476 *Nov 25, 2002May 27, 2004Chan Tai WahHigh concentration formulations of opioids and opioid derivativesUS20040102762 *Nov 21, 2002May 27, 2004Gilbert Scott JayOsmotic delivery device having a two-way valve and dynamically self-adjusting flow channelUS20040111080 *May 29, 2002Jun 10, 2004Microsolutions, Inc.Methods and implantable devices and systems for long term delivery of a pharmaceutical agentUS20040151753 *Nov 4, 2003Aug 5, 2004Guohua ChenControlled release depot formulationsUS20040157884 *Nov 20, 2003Aug 12, 2004Johnson Randolph MellusDevices and methods for pain managementUS20040243106 *Jul 7, 2004Dec 2, 2004Rupal AyerOsmotic delivery device with membrane plug retention mechanismUS20040249365 *Oct 14, 2003Dec 9, 2004Microsolutions, Inc.Implantable osmotic pumpUS20040267230 *Aug 30, 2002Dec 30, 2004Felix TheeuwesFlow regulatorUS20050008661 *Mar 31, 2004Jan 13, 2005Fereira Pamela J.Non-aqueous single phase vehicles and formulations utilizing such vehiclesUS20050048097 *Oct 8, 2004Mar 3, 2005Rupal AyerOsmotic delivery system with membrane plug retention mechanismUS20050070883 *Nov 21, 2001Mar 31, 2005Brown James EDevices and methods for controlled delivery from a drug delivery deviceUS20050070884 *Mar 31, 2004Mar 31, 2005Dionne Keith E.Osmotic pump with means for dissipating internal pressureUS20050079202 *May 28, 2004Apr 14, 2005Guohua ChenImplantable elastomeric depot compositions and uses thereofUS20050106205 *Aug 18, 2004May 19, 2005Gillis Edward M.Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congenersUS20050129737 *Jan 26, 2005Jun 16, 2005Johnson Randolph M.Devices and methods for pain managementUS20050131389 *Nov 22, 2004Jun 16, 2005Peterson Lewis L.Osmotic delivery system flow modulator apparatus and methodUS20050143789 *Feb 25, 2005Jun 30, 2005Whitehurst Todd K.Methods and systems for stimulating a peripheral nerve to treat chronic painUS20050154419 *Mar 4, 2005Jul 14, 2005Whitehurst Todd K.Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical conditionUS20050192638 *Jul 28, 2004Sep 1, 2005Mark GelfandMethods and devices for renal nerve blockingUS20050228451 *Jun 17, 2005Oct 13, 2005Jaax Kristen NMethods and systems for treating chronic pelvic painUS20050266087 *May 19, 2005Dec 1, 2005Gunjan JunnarkarFormulations having increased stability during transition from hydrophobic vehicle to hydrophilic mediumUS20050267555 *May 24, 2005Dec 1, 2005Marnfeldt Goran NEngagement tool for implantable medical devicesUS20050276856 *Jul 18, 2005Dec 15, 2005Fereira Pamela JNon-aqueous single phase vehicles and formulations utilizing such vehiclesUS20050281877 *Aug 2, 2005Dec 22, 2005Guohua ChenOsmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systemsUS20060013879 *Aug 19, 2002Jan 19, 2006Brodbeck Kevin JGel composition and methodsUS20060036293 *Jul 29, 2005Feb 16, 2006Whitehurst Todd KMethods for treating gastrointestinal disordersUS20060064140 *Oct 7, 2005Mar 23, 2006Whitehurst Todd KMethods and systems for stimulating a trigeminal nerve to treat a psychiatric disorderUS20060116641 *Jul 1, 2005Jun 1, 2006Microlin, L.C.Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated methodUS20060116665 *Sep 27, 2005Jun 1, 2006Gilbert Scott JOsmotic delivery device having a two-way valve and a dynamically self-adjusting flow channelUS20060129201 *Dec 6, 2005Jun 15, 2006Lee Philip H JStimulation of the stomach in response to sensed parameters to treat obesityUS20060149340 *Jan 27, 2006Jul 6, 2006Karunasiri Rankiri TSystems and methods for providing power to one or more implantable devicesUS20060153844 *Dec 29, 2005Jul 13, 2006Thomas KundigMethods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organsUS20060153858 *Dec 19, 2005Jul 13, 2006Kundig Thomas MMethod of inducing a CTL responseUS20060161217 *Dec 21, 2005Jul 20, 2006Jaax Kristen NMethods and systems for treating obesityUS20060193918 *Feb 3, 2006Aug 31, 2006Rohloff Catherine MSolvent/polymer solutions as suspension vehiclesUS20060194724 *Feb 25, 2005Aug 31, 2006Whitehurst Todd KMethods and systems for nerve regenerationUS20060235484 *Oct 25, 2005Oct 19, 2006Jaax Kristen NStimulation of a stimulation site within the neck or headUS20060246138 *Mar 13, 2006Nov 2, 2006Rohloff Catherine MPolyoxaester suspending vehicles for use with implantable delivery systemsUS20060247728 *Jun 30, 2006Nov 2, 2006Foster Allison MMethods and systems for treating autism by decreasing neural activity within the brainUS20060264913 *Jun 27, 2006Nov 23, 2006Poutiatine Andrew IImplantable flow regulator with failsafe mode and reserve drug supplyUS20060293723 *Dec 17, 2004Dec 28, 2006Whitehurst Todd KSkull-mounted electrical stimulation system and method for treating patientsUS20070014820 *Jun 27, 2006Jan 18, 2007Dana LitmanovitzOpioid formulationsUS20070027105 *Jul 24, 2006Feb 1, 2007Alza CorporationPeroxide removal from drug delivery vehicleUS20070038264 *Dec 21, 2005Feb 15, 2007Jaax Kristen NMethods and systems for treating autismUS20070049988 *Dec 30, 2005Mar 1, 2007Rafael CarbunaruOptimal electrode contact polarity configurations for implantable stimulation systemsUS20070066997 *Sep 21, 2005Mar 22, 2007He Tom XMethods and systems for placing an implanted stimulator for stimulating tissueUS20070083240 *Dec 7, 2006Apr 12, 2007Peterson David K LMethods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulatorUS20070087058 *Dec 11, 2006Apr 19, 2007Peery John ROsmotic implant with membrane and membrane retention meansUS20070112404 *Nov 16, 2005May 17, 2007Mann Alfred EImplantable stimulatorUS20070117841 *Oct 21, 2004May 24, 2007Ozes Osman NUse of pirfenidone in therapeutic regimensUS20070156180 *Dec 30, 2005Jul 5, 2007Jaax Kristen NMethods and systems for treating osteoarthritisUS20070184084 *Oct 30, 2006Aug 9, 2007Guohua ChenImplantable elastomeric caprolactone depot compositions and uses thereofUS20070191818 *Apr 10, 2007Aug 16, 2007Dionne Keith EOsmotic pump with means for dissipating internal pressureUS20070219595 *Mar 14, 2006Sep 20, 2007Advanced Bionics CorporationStimulator system with electrode array and the method of making the sameUS20070250136 *Mar 29, 2006Oct 25, 2007Karunasiri Rankiri TSystems and methods of facilitating communication between a first and second deviceUS20080027513 *Jul 8, 2005Jan 31, 2008Advanced Bionics CorporationSystems And Methods For Using A Butterfly Coil To Communicate With Or Transfer Power To An Implantable Medical DeviceUS20080071253 *Sep 16, 2007Mar 20, 2008Alza CorporationOsmotic Delivery System Flow Modulator Apparatus and MethodUS20080112994 *Jan 11, 2008May 15, 2008Intarcia Therapeutics, Inc.Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic mediumUS20080131398 *Aug 21, 2007Jun 5, 2008United Therapeutics CorporationCombination therapy for treatment of viral infectionsUS20090035252 *May 3, 2006Feb 5, 2009Kundig Thomas MMethod of inducing a CTL responseUS20090192565 *Jul 30, 2009Boston Scientific Neuromodulation CorporationStimulation of the stomach in response to sensed parameters to treat obesityUS20090270944 *Oct 29, 2009Boston Scientific Neuromodulation CorporationMethods and systems for treating a psychotic disorderUS20090281605 *Nov 12, 2009Boston Scientific Neuromodulation CorporationEngagement tool for implantable medical devicesUS20090304636 *Nov 13, 2006Dec 10, 2009Enterprise Partners Venture CapitalStem Cell Factor Therapy for Tissue InjuryUS20100030287 *Oct 8, 2009Feb 4, 2010Boston Scientific Neuromodulation CorporationMethods for treating autismUS20100114074 *Dec 29, 2009May 6, 2010Intarcia Therapeutics, Inc.Sustained delivery of an active agent using an implantable systemUS20110009920 *Jul 13, 2010Jan 13, 2011Boston Scientific Neuromodulation CorporationSkull-mounted electrical stimulation system and method for treating patientsUS20110029042 *Oct 12, 2010Feb 3, 2011Boston Scientific Neuromodulation CorporationLead assemblies with one or more switching networksUS20110060382 *Mar 10, 2011Boston Scientific Neuromodulation CorporationStimulation of a stimulation site within the neck or headUS20110136847 *Jun 9, 2011Tai Wah ChanHigh Concentration Formulations of Opioids and Opioid DerivativesUS20110143648 *Jun 16, 2011Oy Halton Group Ltd.Automatic displacement ventilation system with heating modeUS20110172739 *Jul 14, 2011Boston Scientific Neuromodulation CorporationImplantable stimulatorUS20110230865 *Sep 22, 2011Intarcia Therapeutics, Inc.Sustained delivery of an active agent using an implantable systemUS20110269131 *Oct 28, 2009Nov 3, 2011Chiu Daniel TSubstrate for manufacturing disposable microfluidic devicesEP0783896A1 *Oct 7, 1996Jul 16, 1997Siemens Elema ABDosing deviceEP2030611A1Jul 28, 2003Mar 4, 2009Alza CorporationInjectable multimodal polymer depot compositions and uses thereofEP2311431A1Jun 25, 2003Apr 20, 2011ALZA CorporationShort duration depot formulationsEP2316421A1Jun 25, 2003May 4, 2011ALZA CorporationBupivacaine-containing injectable depot compositionEP2390262A1May 13, 2004Nov 30, 2011Intermune, Inc.Synthetic chemokine receptor ligands and methods of use thereofEP2583717A2Nov 17, 2004Apr 24, 2013Ardian, Inc.Methods and devices for renal nerve blockingWO1998020930A1Nov 7, 1997May 22, 1998Alza CorpOsmotic delivery system and method for enhancing start-up and performance of osmotic delivery systemsWO2002085428A2 *Apr 3, 2002Oct 31, 2002Microsolutions IncImplantable osmotic pumpWO2004022069A1Sep 6, 2002Mar 18, 2004Yves ChristenDelivery of modulators of glutamate-mediated neurotransmission to the inner earWO2004089457A1Mar 31, 2004Oct 21, 2004Alza CorpOsmotic pump with means for dissipating internal pressureWO2007059010A2Nov 13, 2006May 24, 2007Entpr Partners Venture CapitalStem cell factor therapy for tissue injuryWO2010107739A2Mar 16, 2010Sep 23, 2010The Board Of Trustees Of The Leland Stanford Junior UniversityMethods and compositions of treating a flaviviridae family viral infectionWO2012175698A1Jun 22, 2012Dec 27, 2012Universit� Libre de BruxellesTherapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver diseaseWO2013033636A2Aug 31, 2012Mar 7, 2013University Of Southern CaliforniaMethods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same* Cited by examinerClassifications U.S. Classification424/424, 604/892.1, 424/468International ClassificationA61K9/00Cooperative ClassificationA61K9/0004European ClassificationA61K9/00L4Legal EventsDateCodeEventDescriptionJul 17, 1990CCCertificate of correctionFeb 24, 1993FPAYFee paymentYear of fee payment: 4Mar 11, 1997FPAYFee paymentYear of fee payment: 8Mar 9, 2001FPAYFee paymentYear of fee payment: 12RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services


text:
Patent US6273087 - Respiratory aid - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsA tubular respiratory assistance device which forms the wall of a main channel and is intended to be connected by its distal end to a patient's airway, so that the main channel connects the patient's respiratory system to the outside, and which has at least one auxiliary channel which is associated with...http://www.google.com/patents/US6273087?utm_source=gb-gplus-sharePatent US6273087 - Respiratory aidAdvanced Patent SearchPublication numberUS6273087 B1Publication typeGrantApplication numberUS 09/319,307Publication dateAug 14, 2001Filing dateOct 26, 1998Priority dateOct 27, 1997Fee statusPaidAlso published asCA2274021A1, CA2274021C, CN1182888C, CN1242711A, DE69815464D1, DE69815464T2, EP0911051A1, EP0911051B1, WO1999021603A1Publication number09319307, 319307, US 6273087 B1, US 6273087B1, US-B1-6273087, US6273087 B1, US6273087B1InventorsGeorges Boussignac, Jean-Claude LabruneOriginal AssigneeGeorges Boussignac, Jean-Claude LabruneExport CitationBiBTeX, EndNote, RefManPatent Citations (24), Referenced by (17), Classifications (22), Legal Events (3) External Links: USPTO, USPTO Assignment, EspacenetRespiratory aidUS 6273087 B1Abstract A tubular respiratory assistance device which forms the wall of a main channel and is intended to be connected by its distal end to a patient's airway, so that the main channel connects the patient's respiratory system to the outside, and which has at least one auxiliary channel which is associated with deflection means for injecting a respiratory gas jet which is deflected toward the interior of the main channel and is intended to ventilate the patient. The tubular respiratory assistance device also has an annular chamber arranged at the periphery of it, coaxially with it on its distal end, and a distal annular orifice, the annular chamber communicating with the patient's respiratory system by means of the distal annular orifice and being provided with means for connection to the outside. Also, a respiratory assistance mask intended to be fitted to a patient's face which has this tubular respiratory assistance device for inlet and outlet of respiratory gas.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3661528Apr 2, 1970May 9, 1972Instrumentation Associates IncBreath samplerUS3881480 *Mar 7, 1973May 6, 1975Lafourcade Jean MichelBreathing aid apparatusUS4207884 *Jul 17, 1978Jun 17, 1980Max IsaacsonPressure controlled breathing apparatusUS4558708 *Oct 24, 1984Dec 17, 1985Tri-Med, Inc.Patient's airway adapter to withdraw a patient's gas samples for testing free of sputum mucus and/or condensed water, by utilizing a hollow cylindrical hydrophobic liquid baffleUS4592349 *Jul 21, 1983Jun 3, 1986Bird F MVentilator having an oscillatory inspiratory phase and methodUS4679573 *Aug 11, 1986Jul 14, 1987Andros Analyzers IncorporatedAdaptor assembly for airway tubeUS4852583 *Jan 16, 1987Aug 1, 1989Spacelabs, Inc.Airway adapterUS5036847Mar 29, 1990Aug 6, 1991Georges BoussignacBreathing aidUS5166075 *Apr 24, 1992Nov 24, 1992Nellcor IncorporatedMethod for determining whether respiratory gas is present in a gaseous sampleUS5335656 *Oct 21, 1992Aug 9, 1994Salter LaboratoriesMethod and apparatus for inhalation of treating gas and sampling of exhaled gas for quantitative analysisUS5452715Dec 29, 1993Sep 26, 1995Boussignac; GeorgesTube for assisting breathingUS5465728 *Jan 11, 1994Nov 14, 1995Phillips; MichaelBreath collectionUS5474060Aug 23, 1993Dec 12, 1995Evans; DavidFace mask with gas sampling portUS5538002Oct 20, 1994Jul 23, 1996Boussignac; GeorgesDevice for respiratory assistanceUS5642726 *Apr 9, 1996Jul 1, 1997Alcove Medical, Inc.Reduced internal volume neonatal suction adaptorUS5789660 *Jul 15, 1996Aug 4, 1998Novametrix Medical Systems, Inc.Multiple function airway adapterUS5893361 *Jun 12, 1998Apr 13, 1999Hughes; Arthur R.Acoustic transceiver respiratory therapy apparatus and methodUS5979444 *Jun 17, 1997Nov 9, 1999Sherrod; James B.Portable CPR breathing apparatusUS6129680 *Dec 18, 1997Oct 10, 2000Btg International LimitedAnimal exhalation monitoringEP0390684A1Mar 29, 1990Oct 3, 1990Georges BoussignacRespiratory assistance deviceEP0640355A1Jul 29, 1994Mar 1, 1995Georges BoussignacTube for respiratory assistanceEP0701834A1Sep 6, 1995Mar 20, 1996Georges BoussignacRespiratory assistance deviceGB2267661A Title not availableWO1997006843A1Aug 15, 1996Feb 27, 1997Gassner TsviA computer controlled portable ventilator* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS6363935 *Sep 1, 1999Apr 2, 2002Georges BoussignacDevice for respiratory assistanceUS6378517 *May 18, 2000Apr 30, 2002DR�GER MEDIZINTECHNIK GMBHCoupling for a breathing tube systemUS6484724 *Jul 31, 2000Nov 26, 2002Ian Alexander SloanUniversal respiratory device couplerUS6761172 *Feb 21, 2003Jul 13, 2004Georges BoussignacDevice for respiratory assistanceUS6814075 *Nov 5, 2002Nov 9, 2004Georges BoussignacRespiratory assistance deviceUS7562659 *Jul 22, 2003Jul 21, 2009Hasdi MatarassoRespiratory aid apparatus and methodUS7726313 *Mar 17, 2005Jun 1, 2010DR�GERWERK AKTIENGESELLSCHAFTBreathing mask with individual adaptation to the shape of the faceUS7749169 *Apr 8, 2004Jul 6, 2010Intoximeters, Inc.Handheld breath tester housing and mouthpieceUS7841988 *Jul 6, 2007Nov 30, 2010Nihon Kohden CorporationNasal mask for carbon dioxide gas measurementUS7927285 *Jun 30, 2008Apr 19, 2011Nihon Kohden CorporationNasal mask for carbon dioxide gas measurementUS8312882Mar 29, 2007Nov 20, 2012Georges BoussignacArtificial respiration device for patients suffering from hypoxemia or anoxemiaUS8336549 *Jun 1, 2007Dec 25, 2012Ramses NashedDisposable anesthesia face maskUS8534286Aug 25, 2009Sep 17, 2013Carefusion 2200, Inc.Nasal continuous positive airway pressure device and systemUS20100132706 *Feb 1, 2010Jun 3, 2010Ramses NashedRespiratory face mask and breathing circuit assemblyUS20120012114 *Sep 21, 2011Jan 19, 2012Respcare, Inc.Hybrid ventilation mask with nasal interface and method for configuring such a maskEP1618912A1 *Jul 18, 2005Jan 25, 2006Fabrice GhironAnschlussst�ck f�r SauerstoffmaskeWO2008063197A1 *Jan 4, 2007May 29, 2008Martin Christopher SSnap-in deflector for respiratory mask* Cited by examinerClassifications U.S. Classification128/204.22, 128/205.23, 600/543, 600/531, 128/200.12, 128/204.23, 600/532, 128/204.25, 128/912, 128/202.27, 128/202.22International ClassificationA61M16/12, A61M16/08, A61M16/00Cooperative ClassificationY10S128/912, A61M2016/0858, A61M2016/125, A61M16/12, A61M2205/75, A61M2016/085, A61M2230/432European ClassificationA61M16/12Legal EventsDateCodeEventDescriptionJan 4, 2013FPAYFee paymentYear of fee payment: 12Feb 17, 2009FPAYFee paymentYear of fee payment: 8Jan 11, 2005FPAYFee paymentYear of fee payment: 4RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services©2012 Google

type: global

value: This website is a search engine provided by Google. Handling over 3.5 billion searches per day, it has a 92% share of the global search engine market.


text:
Steele, Richard Sir 1672-1729 [WorldCat.org]
Steele, Richard Sir 1672-1729 Overview
Periodicals Criticism, interpretation, etc History Biography Sources Pamphlets Records and correspondence Fiction Portraits Anecdotes Roles:
Author, Editor, Redactor, Translator, Author of introduction, Other, Composer, Correspondent, Publishing director, Contributor, Creator, Attributed name, Compiler, Actor, Secretary
Richard Steele, published posthumously.
Sir Richard Steele by Willard Connely(
Captain Steele; the early career of Richard Steele by Calhoun Winton(
Steele at Drury Lane by John Clyde Loftis(
Sir Richard Steele, M.P.: the later career by Calhoun Winton(
Richard Steele by Richard H Dammers(
The correspondence of Richard Steele by Richard Steele(
Richard Steele by Austin Dobson(
The first ode of the second book of Horace paraphras'd and address'd to Richard St--le, Esq by Jonathan Swift(
Essays biographical, critical, and historical, illustrative of the Tatler, Spectator, and Guardian by Nathan Drake(
The honour and prerogative of the Queen's Majesty vindicated and defended against the unexampled insolence of the author of the Guardian: in a letter from a Country Whig to Mr. Steele by Daniel Defoe(
The case of Richard Steele Esq; being an impartial account of the proceedings against him. In a letter to a friend by Richard Steele(
The character of Richard St-le, Esq ; with some remarks. By Toby, Abel's Kinsman ; or, according to Mr. Calamy, A.F. & N. in a letter to his godfather by William Wagstaffe(
The characters and conduct of Sir John Edgar call'd by himself sole monarch of the stage in Drury-Lane ; and his three deputy-governors. In two letters to Sir John Edgar by John Dennis(
The conscious lovers A comedy. As it is acted at the Theatre Royal in Drury-Lane, by His Majesty's servants. Written by Sir Richard Steele by Richard Steele(
The funeral; or, grief a-la-mode. a comedy, by Sir Richard Steele, adapted for theatrical representation, as performed at the Theatre-Royal, Covent-Garden. Regulated from the prompt-book. By permission of the manager. by Richard Steele(
The tender husband by Richard Steele(
The Christian hero by Richard Steele(
The lying lover or, the ladies friendship. A comedy. Written by Sir Richard Steele by Richard Steele(
The conscious lovers by Richard Steele(
The crisis: or, a discourse representing, from the most authentick records, the just causes of the late happy revolution: and the several settlements of the crowns of England and Scotland ... With some seasonable remarks on the danger of a popish successor. By Richard Steele, Esq by Richard Steele(
The dramatick works of Sir Richard Steele. Containing, The conscious lovers. The funeral. The tender husband. The lying lover by Richard Steele(
Spectator club by Richard Steele(
The ladies library by Richard Steele(
Tracts and pamphlets by Richard Steele(
The guardian by Richard Steele(
Addison and Steele: selections from the Tatler and the Spectator by Joseph Addison(
A letter to a Member of Parliament concerning the bill for preventing the growth of schism. By Richard Steele, esq by Richard Steele(
The importance of Dunkirk consider'd in defence of the guardian of August the 7th : in a letter to the bailiff of Stockbridge by Richard Steele(
The plays of Richard Steele by Richard Steele(
Spectator ... to
Essays bio
Addison, Joseph 1672-1719 Publishing director Translator Author Editor Redactor Budgell, Eustace 1686-1737 Author Blanchard, Rae Other Author Editor Aitken, George Atherton 1860-1917 ed Author Editor Swift, Jonathan 1667-1745 Author Winton, Calhoun Author Editor Smith, G. Gregory (George Gregory) 1865-1932 Editor Bond, Donald Frederic 1898-1987 Author Editor Loftis, John Clyde 1919- Author Editor Dobson, Austin 1840-1921 Author Editor Useful Links
Wikipedia Richard Steele
Addison, Joseph, Authors, English Authors, Irish Canon (Literature) Christian life Church and state Civilization Conduct of life Criticism Criticism and interpretation Dramatists, English Emblem books, English England England--London English drama English drama (Comedy) English drama--Restoration English essays English literature English literature--Study and teaching (Higher) English periodicals English wit and humor Essays France France--Dunkerque Friendship Great Britain Halifax, Charles Montagu,--Earl of, Intellectual life International relations Jacobite Rebellion (1715) Journalism Journalists Kings and rulers--Succession Manners and customs Marlborough, John Churchill,--Duke of, Newspapers Political and social views Political science Politicians Spanish Succession, War of (1701-1714) Spectator (London, England : 1711) Steele, Richard,--Sir, Tatler (London, England : 1709) Theater Theatre Royal, Drury Lane (London, England) United States Women Women--Conduct of life Women--Social conditions Alternative Names
author of the Tatler and Spectator, the 1672-1729Bickerstaf, Isaak 1672-1729Bickerstaff, Isaac 1672-1729Bickerstaffe, Isaac 1672-1729Edgar John 1672-1729Edgar, John 1672-1729 SirEdgar, John, Sir, 1672-1729.Gentleman of the army.Gentleman of the army 1672-1729Ironside, Nestor 1672-1729Mr Steele 1672-1729Myrtle Marmaduke 1672-1729R-d S-e 1672-1729 SirR-d S-e, Sir, 1672-1729S-e, R-d 1672-1729 SirS-e, R-d, Sir, 1672-1729Steel, Richard 1672-1729Steele.Steele, .. 1672-1729Steele 1672-1729 MrSteele, Mr.Steele, Mr 1672-1729Steele, Mr. (Richard), 1672-1729.Steele, R.Steele, R. 1672-1729Steele, R. 1672-1729 SirSteele, R. (Richard) 1672-1729Steele, R. (Richard), Sir, 1672-1729.Steele, RichardSteele, Richard 1672-1729Steele, Richard SirSteeli Riccardo 1672-1729

value: This website is a union catalog that itemizes the collections of 15,637 libraries in 107 countries that participate in the OCLC global cooperative. It is operated by OCLC, Inc.


text:
Patent US20050108148 - System and method of investing in a market - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsA system and method directed to an investment strategy that focuses on buying the worst-performing stocks in terms of percentage price change over the last twelve months in the Dow Jones Industrial Average. Specifically, an investor in one embodiment buys one or more of the worst performers, holds the...http://www.google.com/patents/US20050108148?utm_source=gb-gplus-sharePatent US20050108148 - System and method of investing in a marketAdvanced Patent SearchPublication numberUS20050108148 A1Publication typeApplicationApplication numberUS 10/980,417Publication dateMay 19, 2005Filing dateNov 2, 2004Priority dateNov 17, 2003Publication number10980417, 980417, US 2005/0108148 A1, US 2005/108148 A1, US 20050108148 A1, US 20050108148A1, US 2005108148 A1, US 2005108148A1, US-A1-20050108148, US-A1-2005108148, US2005/0108148A1, US2005/108148A1, US20050108148 A1, US20050108148A1, US2005108148 A1, US2005108148A1InventorsCharles CarlsonOriginal AssigneeCharles CarlsonExport CitationBiBTeX, EndNote, RefManReferenced by (16), Classifications (4) External Links: USPTO, USPTO Assignment, EspacenetSystem and method of investing in a market
A variation of the �long-short� investment method includes buying the five worst-performing DJIA stocks while going short on the five best-performing DJIA stocks. Alternatively, an investor can go long on the DJIA stock that is trading the greatest percentage below its two-hundred day moving average while shorting the DJIA stock trading the greatest percentage above its two-hundred day moving average. The investment method includes purchasing interests in altered value items of trade other than an ownership interest in the item of trade itself. In one embodiment, futures and options are employed in the investment method. Two types of options include an option to purchase the altered value item of trade at a particular within a certain period of time, a �call�, or an option to sell the altered value item of trade, a �put�, at a particular price within a certain period of time. It should be appreciated that the investor can trade other interests or rights in an item of trade in a market for those interests and rights. All thirty DJIA stocks have call and put options available for purchase. Accordingly, an investor who wants to implement any variation of the strategy of the invention can do so using put and call options rather than or in addition to buying and shorting the underlying stocks. In one example, one option gives the investor the right to purchase one hundred shares of an underlying stock. Purchasing options instead of the stock allows an investor, in addition to the increased leverage, to implement the method of the invention with less initial capital investment. To buy one hundred shares in each of the five stocks in 2003 would entail an investment of more than $15,700. However, to purchase an interest in the equivalent of one hundred shares in each of the companies through purchase of a single call option in each of the five companies (assuming one bought call options with a strike price that matched the current stock price) would have entailed a much smaller investment, as low as $1,000 if one purchased relatively short-term options (expiring within three months). The price of an option includes a �premium� to obtain the option. Option premiums are determined by a variety of factors. An important driver of option premiums is the underlying volatility of the stock: the more volatile the stock, the higher the cost of the option premium. For example, if an investor pays $500 to purchase a call option in American Express at $40 per share, the investor becomes the owner of the right or option to purchase one hundred shares of American Express stock anytime over the next nine months at $40 per share. If the stock soars from $40 to $50 in four months, the value of each option is at least $10 per call option. If its value was less than $10, the investor exercises the options, buys American Express at $40, and immediately sells at $50 for a gain of at least $10 per share. Actually, the call option will be worth more than $10 since the premium will reflect the fact that there are still five months remaining before the option expires. In this scenario, the initial investment has at least doubled to $1,000. In other words, in just four months, the investment has gained 100% or more. Compare that gain to the gain had one bought the stock instead of the option. The gain in American Express stock would only be 25% (a $10 gain on a $40 purchase price), a good return for four months, but less than the gain on the call option. If an investor believes that American Express stock is overpriced at $40 per share and will drop to at least $30 over the next nine months, but is not comfortable selling short American Express, the investor may buy a �put� option to leverage this bet. As mentioned above, a put option gives an investor the right to sell a stock at a given price. If the investor purchases a put option on American Express with a strike price of $40 and with a nine-month life, that option gives the investor the right to sell American Express stock at $40 per share anytime during the next nine months. Again the investor pays an option premium of $500 for the put option. If, instead of rising to $50 per share, American Express drops to $30, the value of the put option is worth at least $10. Again, the put option gives one the right to sell the stock at $40. However, investors cannot sell something they do not own. Therefore, the investor exercises the put option and sells the stock at $40 per share. To cover that sell, the investor buys back the stock and, in this case, would buy back the stock at $30 per share. Thus, the profit would be $10 (selling at $40 and buying at $30). As in the previous case, the value of the option doubled, from $500 to $1,000. Thus, the gain on the put options is 100%. Options have a limited lifespan. The longer the life of the option, the greater its value as a result of the �time premium.� However, as time elapses and the option gets closer and closer to its expiration date, the time premium shrinks and eventually disappears. If, for example, an investor bought an American Express call option with a strike price at $40 and the stock trades for $39 at the end of the option's life, the option would expire worthless. That is because an option to buy a stock at $40 that is trading for $39 has no value at all. Therefore, an investor, has to be right about the direction of the underlying stock and has to see that idea come to fruition in a fairly limited period of time. It should be appreciated that being right about a stock and right about its timing is difficult to do successfully over time. Accordingly, to employ the investment strategy of the present invention on the first day of trading in 2003 buying options in the five worst performers in 2002, rather than stock, the investor purchases options on Home Depot at $24.02 per share, Intel at $15.57 per share, McDonalds at $16.08 per share, General Electric at $24.35 per share, and IBM at $77.50 per share. Although most options have a maximum nine-month life, a form of option exists that provides investors with an option life of more than twelve months which is compatible with the preferred holding time period of the present invention. In one embodiment, the investment strategy of the invention includes purchasing options in an altered value item of trade that have a term of at least twelve months known as Long-Term Equity Anticipation Securities (�LEAPS�). LEAPS are long-term call and put options. LEAPS are purchased on the various options exchanges the same way and in the same dollar increments as call and put options and are available for all DJIA stocks. In one example, one LEAP call is the equivalent of having an option to buy one hundred shares of the underlying stock. One LEAP put is the equivalent of having an option to sell one hundred shares of an underlying stock. Like options, LEAP values reflect both a time premium as well as a price premium. Thus, the closer the LEAP is to expiration, the less the time premium in the LEAP price. LEAPS are attractive vehicles for implementing an aggressive form of investment method of the present invention. First, LEAPS provide substantial leverage for investors. Since LEAPS are options, gains in the underlying stock will create even bigger percentage gains in the LEAP. Of course, losses in the underlying stock results in even greater losses, on a percentage basis, in the LEAP. Second, buying LEAPS is as easy as buying common stocks or call and put options with a margin account at a broker. Any method employing stocks can be employed at a predetermined time period using LEAPS. For example, if an investor believes that the worst-performing DJIA stock will do well and the best-performing DJIA stock will decline, the investor can buy the LEAP call option on the worst performer and the LEAP put option on the best performer to simulate a �long-short� strategy. The investor can also combine LEAPS and stocks. For example, the investor can go long on the worst-performer by buying the stock while buying a LEAP put option on the best performer. Under an exemplary embodiment, the investment strategy includes buying a LEAP that has a lifespan greater than twelve months. On the first day of each year, for example, the method of the invention can include purchasing LEAPS of the five most altered value items of trade over the last twelve months. Alternatively, the invention can include buying the LEAP of the most altered value items of trade that is trading the greatest percentage above or below its two-hundred day moving average. Like regular call and put options, LEAPS expire after the third Friday of the expiration month and the last trading day for the LEAP is the business day preceding that Saturday. It should be appreciated that strategies employing options and LEAPS may not always be tax friendly relative to owning and holding the underlying stocks for more than twelve months. Indeed, all gains on traditional call and put options are taxed at ordinary income rates because they have a maximum life of nine months. Furthermore, the current tax rules governing LEAPS are complicated in terms of defining short-term and long-term gains. In one embodiment, the invention is used to enhance an otherwise conservative portfolio. For example, the invention can enhance an investment in an index, such as in the Dow Jones Industrial Average, referred to herein as an enhanced index investment. An enhanced index investment attempts to generate superior returns to the index while not straying too far from the performance of the underlying index. One reason enhanced indexes are appealing to investors is that, on the one hand, an enhanced index investment is usually going to perform close to the underlying index. Thus, an investor who does not want too much variation in returns over time from a particularly stable index will feel comfortable owning an enhanced index fund. On the other hand, the fact that it is an �enhanced� index investment gives an investor the possibility of outperforming the index over time. It should be appreciated that multiple ways of purchasing a variety of interests can be combined and applied to the investment strategy of the present invention. The method includes determining the portion of the initial investment to be allocated to an item of trade tied directly to the index and the portion the investor wants to invest in �enhancers�. The enhancement portion of the portfolio can include over-weighting the allocation of assets directed toward preferred items of trade and under-weighting the allocation of assets directed toward non-preferred items of trade assets relative to the weighting of the item of trade in the index or any other suitable measure of preference. Obviously, the more assets devoted to the enhancers, the more divergence between the performance of the index and the investment performance. Under an exemplary embodiment, the enhanced index includes an investment in the entire DJIA by buying the Dow �Diamond� (AMEX symbol: DIA). The Diamond is an exchange-traded fund listed on the American Stock Exchange. Exchange-traded funds are a hybrid of a mutual fund and a stock. Like a traditional mutual fund, an exchange-traded fund is a single investment that allows an investor to buy a plurality of stocks. Unlike a traditional open-end mutual fund which does not trade on any stock exchange, exchange-traded funds are similar to stocks. That is, any investor can buy an exchange-traded fund simply by placing an order via the broker. Exchange-traded funds, unlike options, also have no finite life. Furthermore, unlike open-end mutual funds, exchange-traded funds can be bought and sold intraday. Finally, the fees to own exchange-traded funds are rather small, amounting to the commission to purchase the exchange-traded fund and a fairly minimal annual expense fee. According to the investment method of the present invention, a fund or portfolio can be enhanced by combining an investment in the Dow Diamond with a purchase of stocks or LEAPS according to the investment method described above. For example, with an initial investment amount of $10,000 to invest using the investment method, one approach includes investing $8,000 in the Dow Diamonds and investing the remaining $2000 in LEAPS in one or more of the most altered value stocks as described above. If the Dow rises 8% over the year, and the portfolio of the invention increases by 30% for the year, the total $10,000 initial investment grows to $11,240 (the $8,000 in the Diamonds multiplied by the 8% return plus the $2,000 investment in LEAPS multiplied by a 30% return)�a gain of 12.4%, more than four percentage points higher than the DJIA gain of 8%. If the strategy decreases by 30%, the initial $10,000 investment (assuming the same 8% return on the DJIA) would have risen to just $10,040�a gain of 0.4%. In this instance, the investment is nearly eight percentage points worse than the DJIA. However, one would have still made a profit even though one-fifth of the investment had declined 30%. It should be appreciated that the enhanced index approach can be adjusted based on the risk parameters and the desire to stay close to the performance of the underlying index. Another example of an enhanced index approach to the present invention uses a variation of the long/short approach discussed above. In one embodiment, instead of going long on the worst-performing stock and shorting the best-performing stock, LEAP puts and calls are used to replicate a similar bet. In this example, the investor purchases $8000 worth of Dow Diamonds, $1000 in the long LEAP (the �call� LEAP) of the DJIA stock trading the most below its two-hundred day moving average and $1000 in the short LEAP (the �put� LEAP) of the DJIA stock that is trading the greatest percentage above its two-hundred day moving average. The strike price of the LEAPS is close to the actual trading price of the underlying stock and has a lifespan of at least twelve months. Referring back to FIG. 1, after purchasing a particular amount or interest in an altered value item of trade in a market, step S4 includes holding that interest for a predetermined period of time. One embodiment of the present invention includes holding the shares of stock for at least one year. In one embodiment the investor holds the interest in the item of trade for a period of time corresponding to optimizing the tax treatment of any gain or loss from the sale of that item of trade, such as not selling shares of stock until the next trading day after a period of twelve months from the date of purchase. For example, if an investor buys stock on February 15, the earliest the investor can sell and receive favorable capital gains tax treatment is February 16 or the next trading day following the 15th of the following year. Holding the stock for an extra day allows the investor to have any gain from the sale of the stock treated as a long-term capital gain and, under current tax law, at a more favorable rate than a gain from a sale of a stock sold within a year of its purchase. Therefore, the investment method of the present invention includes holding the investments for one year and a day under certain circumstances. Turning short-term gains into long-term gains by holding the stocks in the portfolio an extra day after the twelve months may make a substantial difference in the return if the investor is holding the stocks in a taxable account. For example, if an investor is in the thirty-five percent income tax bracket, under current tax law, any realized gains on investments held twelve months or less will be taxed at thirty-five percent. Holding the investment for an extra day, however, converts any gain on that investment from a short term capital gain to a long-term capital gain which is taxed at a rate of fifteen percent. Therefore, if a portfolio of $10,000 realized a return of twenty percent on the investment (or a gain of $2,000) after holding the investment for twelve months or less, the gain is considered short term and is taxed at a rate of thirty-five percent�a loss of $700 to taxes. The after-tax profit then is $1,300. If the same return is realized after holding the investment for twelve months and a day or more, the gain is considered long-term and is taxed at a rate of fifteen percent�a loss of just $300 to taxes. The after-tax profit then is $1,700. Therefore, by waiting one extra day to sell the positions, the investor pockets an extra $400�or four percent of the original investment. The investment should be held the extra day to take advantage of favorable long-term capital gains tax treatment of any gains if the size of the initial investment is significant, if the investor is in a higher tax bracket, and if the investment strategy is successful in generating larger gains during that year. If the investment strategy of the present invention incurs a loss in a given year, the investor creates a short-term loss by selling after twelve months and not holding the extra day. Of course, if the investment portfolio is held in a tax-deferred account, such as a Roth IRA, the distinction between long-term and short-term gains is moot. It should be appreciated that holding the stock of the portfolio an extra day is not without risk. Indeed, if the stock price drops on the last day, one may have been better off selling and paying taxes on the short-term gain. Probabilities suggest, however, that the chances are just as good that the stock could rise on the extra day, thus enhancing returns. If a company in which the investor has invested spins off a firm to shareholders, the investor, in one embodiment, holds the shares in the spin-off company until the end of the twelve-month holding period and then sells the spin-off. This assumes, of course, that the spin-off does not join the composite index from which stocks for the following year will be selected. Similarly, if during the twelve-month holding period, a stock owned by the investor is dropped from the composite index, in one embodiment, the investor continues to hold the stock through the end of the twelve-month period. Although short-term selling pressures as composite �indexers� sell the dropped stock and buy the stock that is being added, in one embodiment, the investor maintains his position in the dropped stock for simplicity sake and due to the fact that the investment method of the present invention assumes a twelve-month holding period regardless of whether the stock was removed from the index. Referring still to FIG. 1, steps S5 and S6 of the investment method include re-balancing the portfolio upon expiration of the holding period. Re-balancing the portfolio includes step S6 of identifying a new list of the altered value items of trade before step S5 of selling the altered value items of trade of the current portfolio from the previous twelve months. Again, the stable value items of trade are ranked according to their performance over the previous time period and a new set of most altered value items of trade is identified as discussed above. It should be appreciated that one or more of the previously purchased altered value items of trade may continue to be one of the most altered value items of trade. In such a case, in one embodiment, the investor excludes the repeated most altered value item of trade from the re-balanced portfolio. Alternatively, the investor includes the repeated most altered value item of trade in the new re-balanced portfolio and continues to hold same. If the amount invested in each of the items of trade of the portfolio is being kept fairly equal as described above, the investor may have to add more dollars to those investments being held over from a prior year in order to get the weightings reasonably equal. For example, if the value of a $2,000 investment in a stock held over from the previous year has declined by $500 over the previous year, in one embodiment, the investor purchases $500 of additional shares of that stock in order to maintain equal dollar investments in each of the stocks in the portfolio. It should be appreciated, however, that it may not be efficient to incur additional trading costs to bring the weightings exactly in line if the investment in each stock differs by a relatively insignificant amount such as a few hundred dollars. The investment method, continues in step S5 of FIG. 1, includes selling the remaining altered value items of trade. For example, as illustrated in FIG. 4, the investor buys Home Depot stock at $24.02 per share on Dec. 31, 2002 and sells the stock at $34.54 per share on Dec. 31, 2003, for a gain of 49% or $980. Intel is purchased at $15.57 per share on Dec. 31, 2002 and sold at $32.05 per share for a gain of 106.5% or $2,130. McDonalds is purchased at $16.08 per share on Dec. 31, 2002, and sold at $24.85 per share on Dec. 31, 2003 for a gain of 56.3% or $1,136. General Electric is purchased at $24.35 per share on Dec. 31, 2002, and sold at $30.98 per share on Dec. 31, 2003 for a gain of 30.7% or $614. IBM is purchased at $77.50 per share on Dec. 31, 2002 and sold at $92.98 per share for a gain of 20.5% or $410. Therefore, the total return on the $10,000 investment in a five stock portfolio in 2003 is $15,270. The investor, therefore realized a profit of $5,270 ($15,270-$10,000) or a 52.7% total return ($5,270 divided by the initial value of the investment, $10,000). As discussed above, in one embodiment, market orders are placed to insure that the stock will be sold and the proceeds will be readily available to put into the next set of altered value items of trade of the re-balanced portfolio; Therefore, in the illustrated embodiment, after twelve months, on Dec. 31, 2003, or, alternatively, twelve months and one day, January 1 or the next trading day, the investor sells the stocks and purchases shares of stock of the five most altered value performing stocks of 2003, repeating steps S2 to S6 as illustrated in FIG. 1. One aspect of the invention includes reinvesting any dividends earned on the stock owned. In fact, the investment strategy of the present invention assumes that all dividends are reinvested. Therefore, a portion of the return on the investment strategy includes interest paid on cash held in the trading account. To compute the portfolio return for a given year, the investor subtracts the starting investment from the total value of the portfolio on the last day of the holding period including cash, dividends, interest on dividends, etc. The profit or loss is then divided by the starting value to calculate the return. It should be appreciated that the investment method of the present invention is preferably implemented in a software program, over a data network including an internet, video, publications or any other suitable form of communication. As an example, the investment method is implemented on a website. The website can provide support to a user by providing statistics necessary to implement the method of the present invention as well as the embodiment of the investment method. Under the example, a website includes a list of the ten worst-performing stocks over a predetermined period of time which represent the selections at the beginning of a holding period such as a calendar year. The website can provide a list ranking the thirty DJIA stocks on twelve-month percentage price change, from the worst performer to the best, highlighting the ten worst-performing DJIA stocks over the last twelve months as illustrated in FIG. 2. The website can also include the ten stocks with the lowest close ratios at the end of a predetermined period of time such as a calendar year. The close ratio represents the ratio of a stock's price to its moving average price over a predetermined period of time. The website can provide a list ranking the thirty DJIA stocks on the ratio of stock price to 200-day moving average price, from the lowest ratio to the highest ratio, highlighting the ten DJIA stocks with the lowest ratios as illustrated in FIG. 3. The website may also provide examples of different portfolios including the worst-performing stocks over a predetermined period of time such as the last twelve months. Portfolios can include one-stock, three-stock, five-stock, or ten-stock portfolios. Also, the website may provide examples of different portfolios including stocks with the lowest ratio of current stock price to two hundred-day moving average price. In addition, the website can provide updated performance statistics such as percentage price change for the year to date for the portfolios and the distribution of the investment among the stocks in each portfolio. The advantage of the present invention is that one can apply the investment method in a variety of ways and in a variety of investment vehicles according to the level of risk one wants to implement. It should be appreciated that the investment strategy of the present invention can be incorporated into a variety of broader investment approaches as well as a stand-alone portfolio. Furthermore, parts of the investment strategy of the present invention can be incorporated into a portfolio of many stocks. Moreover, the investment strategy of the present invention can be used to balance other investments that are bought or held. It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present invention and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims. Referenced byCiting PatentFiling datePublication dateApplicantTitleUS7472086Aug 29, 2007Dec 30, 2008Barclays Bank PlcMethod of protecting an initial investment value of an investmentUS7475033Sep 6, 2007Jan 6, 2009Barclays Bank PlcMethod of protecting an initial investment value of an investmentUS7533055 *Aug 24, 2005May 12, 2009Jeffrey F. RogatzMethods and systems for ranking and investing in financial instrumentsUS7587352 *Aug 24, 2006Sep 8, 2009Research Affiliates, LlcMethod and apparatus for managing a virtual portfolio of investment objectsUS7664694Sep 22, 2006Feb 16, 2010State Street Global AdvisorsValuation-tilted capitalization weighted investment methods and productsUS7797215Jun 26, 2003Sep 14, 2010Power Financial Group, Inc.System and method for analyzing and searching financial instrument dataUS7917424May 13, 2008Mar 29, 2011Bgc Partners, Inc.Systems and methods for providing financial instruments including contrary positionsUS8015095Feb 3, 2010Sep 6, 2011State Street Global AdvisorsValuation-tilted capitalization weighted investment methods and productsUS8200569Jun 21, 2007Jun 12, 2012Power Financial Group, Inc.Option search criteria testingUS8209252Nov 25, 2008Jun 26, 2012Barclays Bank PlcMethod of and system for protecting an initial investment value of an investmentUS8301535Sep 29, 2000Oct 30, 2012Power Financial Group, Inc.System and method for analyzing and searching financial instrument dataUS8374951 *Sep 7, 2009Feb 12, 2013Research Affiliates, LlcSystem, method, and computer program product for managing a virtual portfolio of financial objectsUS8595123May 7, 2012Nov 26, 2013Power Financial Group, Inc.Option search criteria testingUS8630937Oct 2, 2012Jan 14, 2014Power Financial Group, Inc.System and method for analyzing and searching financial instrument dataUS8732058Oct 17, 2009May 20, 2014Cfph, LlcMethods and systems for combining securities and carbon creditsUS8732061Dec 27, 2001May 20, 2014Bgc Partners, Inc.Creating and trading dynamic securities* Cited by examinerClassifications U.S. Classification705/37International ClassificationG06Q40/00Cooperative ClassificationG06Q40/04European ClassificationG06Q40/04RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services


text:
Words that end in botrain | Words ending in botrain
http://www.thefreedictionary.com/words-that-end-in-botrain
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary 10,132,306,941 visitors served
Words that end in botrain
Found 1 words that end in botrain. Browse our Scrabble Word Finder, Words With Friends cheat dictionary, and WordHub word solver to find words that end with botrain. Or use our Unscramble word solver to find your best possible play! Related: Words containing botrain
10-letter words that end in botrainSee also
10-letter words that end in botrain
Words that end in otrain
Words that end in rbotrain

value: This website is an American online dictionary and encyclopedia that aggregates information from various sources.


text:
Words containing lteachin | Words that contain lteachin
http://www.thefreedictionary.com/words-containing-lteachin
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary 10,212,988,153 visitors served
Found 1 words containing lteachin. Browse our Scrabble Word Finder, Words With Friends cheat dictionary, and WordHub word solver to find words that contain lteachin. Or use our Unscramble word solver to find your best possible play!
14 letter words containing lteachinSee also
14 letter words containing lteachin


text: Sorry, this activity has already happened Nature Tots Sutton Courtenay Environmental Education Centre, Didcot Run by: Berkshire, Buckinghamshire and Oxfordshire Wildlife Trust Similar activities Thursday 4 May THU 4 MAY FREE Youth Football Hanney Youth FC, Wantage Run by: Hanney Youth FC Sunday 7 May SUN 7 MAY FREE Great British Tennis Weekend Cholsey Tennis Club, Cholsey Run by: Lawn Tennis Association Tuesday 23 May TUE 23 MAY All Stars Cricket Sutton Courtenay Cricket Club, Sutton Courtenay Run by: Sutton Courtenay Cricket Club More Autumnwatch activities Getting close to and learning about nature through activities run by nature and wildlife partners. Visit the Autumnwatch website SUN 30 APR Get Active Volunteer Work Party at Witches Oak Water Witches Oak Water, Aston on Trent Run by: Derbyshire Wildlife Trust See more Explore the BBC News News Sport Weather Shop Earth Travel Capital iPlayer Culture Autos Future TV Radio CBBC CBeebies Food iWonder Bitesize Travel Music Earth Arts Make It Digital Taster Nature Local Mobile Site Terms of Use About the BBC Privacy Policy Cookies Accessibility Help Parental Guidance Contact the BBC Advertise with us Ad choices Copyright © 2017 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.

value: This website is the BBC's online service. It is a large network of websites including such high-profile sites as BBC News and Sport, the on-demand video and radio services co-branded BBC iPlayer, the children's sites CBBC and CBeebies, and learning services such as Bitesize.


text:
A Banker's Confession: A Christian Guide to Debt Free Living, Revised: Gary Sanseri: 9781880045343 - Christianbook.com
A Banker's Confession: A Christian Guide to Debt Free Living, Revised
Stock No: WW045343
Back Home Industries / 2006 / Paperback
Debt Reduction× (93)
Gary Sanseri worked in the banking industry for 20 years. In A Banker's Confession: A Christian Guide to Debt FreeLiving, he challenges us to rethink our views of money management in light of Biblical truths. He addresses the issues of home ownership, income, debt, expenses, and the Christian view of usury. You don't have to make the banker rich at your own expense. Paperback.
ISBN-13: 9781880045343
City Christian Publishing / 2004 / Trade Paperback
I'm the author/artist and I want to review A Banker's Confession: A Christian Guide to Debt Free Living, Revised.

value:
This website is a Christian catalog and internet retailer.
Christian Book Distributors was started in 1978 by Stephen Hendrickson, 19 years old and a sophomore at Central Bible College in Springfield, Missouri, out of his parents’ home in Lynn, Massachusetts.


text:
Indonesia Apologizes as Fires Cause Pollution in Region - Bloomberg
Bloomberg Anywhere Remote LoginDownload SoftwareService Center MENU Homepage Markets Stocks Currencies Commodities Rates + Bonds Economics Magazine Benchmark Watchlist Economic Calendar Tech U.S. Global Startups Cybersecurity Digital Media Bloomberg Technology TV Hello World Studio 1.0 Pursuits Cars & Bikes Style & Grooming Spend Watches & Gadgets Food & Drinks Travel Real Estate Art & Design Politics Global Risk Briefing How We’ll Know if Trump Is Making America Great Again Tracking Trump’s Web of Conflicts The Inauguration of Donald J. Trump On the March in Trump’s Capital Opinion View Gadfly Businessweek Subscribe Cover Stories Opening Remarks Etc Features 85th Anniversary Issue Behind The Cover More Science + Energy Graphics Billionaires Game Plan Small Business Personal Finance Live TV Inspire GO The David Rubenstein Show Sponsored Content Bloomberg About The Company Sign In Sign In Subscribe Indonesia Apologizes as Fires Cause Pollution in Region
June 24, 2013, 9:09 PM EDT
President Susilo Bambang Yudhoyono apologized to his neighbors after illegal forest fires in Indonesia shrouded parts of the region with hazardous haze, prompting Malaysia to call for a meeting of Southeast Asian ministers.
“As the president, I apologize and ask for the understanding of our friends in Singapore and Malaysia,” Yudhoyono said in a press briefing in Jakarta yesterday. “We will continue to take responsibility to deal with what’s happening right now.”
Singapore and Malaysia have been plagued for decades by periodic haze from forest fires on Indonesia’s Sumatra island, with regular spats over responsibility. The number of hotspots in Riau province increased to 154 on June 23 from 92 the day before, according to the country’s disaster management agency.
Malaysia is offering to host a meeting of the sub-regional ministerial steering committee on trans-boundary haze in Kuala Lumpur next week, Palanivel said, adding Singapore was supportive of such a summit. The meeting was originally scheduled for Aug. 20-21. The government is awaiting a response from Indonesia, Thailand and Brunei, he said. Singapore’s National Environment Agency didn’t immediately respond to queries.
Indonesia plans to add ground forces to fight fires and increase its ability to extinguish them from the air, Yudhoyono said. The cost should not be an issue, he said.

value: This website is an international news agency headquartered in New York City and a division of Bloomberg L.P. Content produced by Bloomberg News is disseminated through Bloomberg Terminals, Bloomberg Television, Bloomberg Radio, Bloomberg Businessweek, Bloomberg Markets, Bloomberg.com, and Bloomberg's mobile platforms. Since 2015, John Micklethwait has served as editor-in-chief.


text:
Mitt Romney Gets Busted Buying Twitter Followers : politicsjump to contentmy subredditsannouncementsArtAskRedditaskscienceawwblogbookscreepydataisbeautifulDIYDocumentariesEarthPornexplainlikeimfiveFitnessfoodfunnyFuturologygadgetsgamingGetMotivatedgifshistoryIAmAInternetIsBeautifulJokesLifeProTipslistentothismildlyinterestingmoviesMusicnewsnosleepnottheonionOldSchoolCoolpersonalfinancephilosophyphotoshopbattlespicsscienceShowerthoughtsspacesportstelevisiontifutodayilearnedTwoXChromosomesUpliftingNewsvideosworldnewsWritingPromptsedit subscriptionsfront-all-random | gadgets-sports-gaming-pics-worldnews-videos-AskReddit-aww-Music-funny-news-movies-books-history-food-philosophy-television-Jokes-Art-DIY-space-Documentaries-Fitness-askscience-nottheonion-todayilearned-personalfinance-gifs-listentothis-IAmA-TwoXChromosomes-creepy-nosleep-GetMotivated-WritingPrompts-LifeProTips-EarthPorn-explainlikeimfive-Showerthoughts-Futurology-photoshopbattles-mildlyinteresting-dataisbeautiful-tifu-OldSchoolCool-UpliftingNews-InternetIsBeautiful-sciencemore » politicscommentsrelatedother discussions (1)Want to join? Log in or sign up in seconds.|Englishlimit my search to /r/politicsuse the following search parameters to narrow your results:subreddit:subredditfind submissions in "subreddit"author:usernamefind submissions by "username"site:example.comfind submissions from "example.com"url:textsearch for "text" in urlselftext:textsearch for "text" in self post contentsself:yes (or self:no)include (or exclude) self postsnsfw:yes (or nsfw:no)include (or exclude) results marked as NSFWe.g. subreddit:aww site:imgur.com dogsee the search faq for details.advanced search: by author, subreddit...this post was submitted on 21 Jul 20121,763 points (90% upvoted)shortlink: remember mereset passwordloginSubmit a new linkSubmit a new text postpoliticssubscribeunsubscribe3,145,324 readers1,496 users here nowWelcome to /r/Politics! Please read the wiki before participating.
created by speza community for 8 yearsmessage the moderatorsMODERATORSBritishEnglishPoliceDublinBenGreypoCedarWolfexoendoJakeableMeghanAMThe1RGoodluckyarcadezaikanekochan...and 20 more »discussions in /r/politics<>X4799 points · 1449 comments Donald Trump: "We’re the most highly taxed nation in the world" Politifact Rating: False1121 points · 333 comments Sanders Within Striking Distance of Clinton in Iowa: Clinton 37%, Sanders 30%86 points · 135 comments Bernie Sanders: Debates Are Rigged for Clinton4842 points · 5110 comments The Democratic Party Adopts $15/hour Minimum Wage into National Platform1081 points · 119 comments What the Mainstream Media Won’t Let Bernie Sanders Talk About - "...it’s not in the interest of the corporations who own the networks to actually be educating the American people so that are debating the real issues."106 points · 36 comments Poll: Sanders surges to within reach of Clinton in Iowa250 points · 13 comments No, the Democratic Party did not adopt the $15/hour minimum wage into its 2016 Platform. The Democratic Party won't adopt their 2016 platform until the summer of 2016 at the Democratic Convention.81 points · 70 comments NASA Scientist Jim Hansen's view: "I believe the biggest obstacle to solving global warming is the role of money in politics."78 points · 16 comments Iowa poll: Bernie Sanders closing in on Hillary Clinton108 points · 112 comments Since no one on the right seems to care when it's one of their own, I'll say it: when the hell do we get to see the birth certificate of Ted Cruz? You know, the one with "born in Canada" written on it.176217631764Mitt Romney Gets Busted Buying Twitter Followers (politicususa.com)submitted 3 years ago by M00N-Watcher290 commentssharesorry, this has been archived and can no longer be voted onloading...sorted by: besttopnewhotcontroversialoldrandomq&ayou are viewing a single comment's thread.view the rest of the comments →[–][deleted] 1 point2 points3 points 3 years ago (1 child)sorry, this has been archived and can no longer be voted onexcept that the top comment in this thread basically says "where's the evidence of this?" and it's full of discussion that hasn't been downvoted and questions or criticizes the sensationalist headline and spurious conclusions people are making about this.
permalinkembedsaveparent[–]the-knife -1 points0 points1 point 3 years ago* (0 children)sorry, this has been archived and can no longer be voted onYeah, I guess. The point about the hivemind still stands. Also read this.
permalinkembedsaveparentgive goldaboutblogaboutvaluesteamsource codeadvertisejobshelpsite rulesFAQwikireddiquettetransparencycontact usapps & toolsAlien Blue iOS appreddit AMA appmobile betabuttons<3reddit goldreddit storeredditgiftsreddit.tvUse of this site constitutes acceptance of our User Agreement and Privacy Policy. © 2015 reddit inc. All rights reserved.REDDIT and the ALIEN Logo are registered trademarks of reddit inc.create a new accountusername:password:verify password:email: (optional)remember meget the best of reddit emailed to you once a week. learn moresign uplog inusername:password:remember mereset passwordlog inBy signing up, you agree to our Terms and that you have read our Privacy Policy and Content Policy.English [en]العربية [ar]Беларуская мова [be]български език [bg]Bosanski [bs]català [ca]česky [cs]dansk [da]Deutsch [de]Ελληνικά [el]English (Australia) [en-au]English (Canadian) [en-ca]English (Great Britain) [en-gb]English [en-us]Esperanto [eo]español [es]español [es-ar]eesti keel [et]Euskara [eu]فارسی [fa]suomi [fi]français [fr]Gàidhlig [gd]עברית [he]मानक हिन्दी [hi]hrvatski [hr]Magyar [hu]Հայերեն լեզու [hy]Bahasa Indonesia [id]íslenska [is]italiano (Italy) [it]日本語 [ja]ಕನ್ನಡ [kn_IN]한국어 [ko]Latin [la]1337 [leet]LOL [lol]lietuvių kalba [lt]latviešu valoda [lv]Nederlands [nl]Nynorsk [nn]Norsk [no]Arrrrrrrr! [pir]polski [pl]português [pt] (*)português [pt-pt]português brasileiro [pt_BR]română [ro]русский [ru]slovenčina [sk]slovenščina [sl]српски језик [sr]Srpski [sr-la]Svenska [sv]தமிழ் [ta]ภาษาไทย [th]Türkçe [tr]українська мова [uk]Tiếng Việt [vi]中文 [zh] (*) incomplete volunteer to translateπ Rendered by PID 14228 on app-143 at 2015-08-30 08:22:22.804987+00:00 running b987d10 country code: US.

value: This website is an American social news aggregation, web content rating, and discussion website. Registered members submit content to the site such as links, text posts, images, and videos, which are then voted up or down by other members.


text:
Caldwell Dress & Formal Shoes for Men | eBay
Caldwell Dress & Formal Shoes for Men
Cole Haan Mens Caldwell Lace Up Cap Toe Oxford Shoes, Black, US 10
Cole Haan Mens 'Caldwell' Lace Up Cap Toe Oxford. Lace Up Front Closure With Five Eyelets. 100% Authentic. Closed Rounded Cap Toe. 24 hour. Department: Mens. Style Name: Caldwell. Style Number: 08330.
Cole Haan Mens 'Caldwell' Lace Up Cap Toe Oxford. Lace Up Front Closure With Five Eyelets. Closed Rounded Cap Toe. Materials: Leather Upper, Leather Lining, Leather Sole, Leather/Rubber Heel. Style Name: Caldwell.
Cole Haan Lenox Hill Cap Toe Oxford Wide Width Available
Cole Haan Mens Caldwell Lace Up Cap Toe Business Casual Dress Formal Shoes
Stacy Adams Men's Caldwell Oxford Cap Toe Leather Shoes - Choose SZ/Color
AU $83.32 to AU $95.15
Cole Haan Men's 08331 - Caldwell 7 D
Dress yourself up with this stylish pair of Caldwell oxfords for men from Cole Haan. Men's Shoes Women's Shoes Kid's Shoes Accessories. Men's Shoes6 6.5 7 7.5 8 8.5 9 9.5 10 10.5 11 12 13 14 15 16 all.
Cole Haan Men's Caldwell Lace-Up Derby Oxford Leather Dress Shoe
Cole Haan Men's Caldwell - Choose SZ/Color
Stacy Adams Caldwell Mens Oxford- Choose SZ/Color.
AU $71.60 to AU $166.92
Mens Cole Haan 10 D Caldwell Black Leather Captoe Dress Shoes
A dress classic! The Caldwell from Cole Haan. Leather uppers and soles, with nearly no wear and some very minor scuffing. Cole Haan Caldwell. Always Authentic Kingdom-Purpose has sold over 50,000 pair of shoes!
Stacy Adams Men's Caldwell 24904
Cole Haan Caldwell Mens Size 11 Burgundy Red Leather Shoes Lace-Up Oxfords Italy
Scratched and scuffed in places. Worn soles.
Cole Haan Men's Caldwell Lace-Up Derby Shoe - Choose SZ/Color
AU $153.77 to AU $379.66
Cole Haan Caldwell Oxfords Mens Sz 9 D Medium Black Leather Dress Formal Solid
Cole Haan Men's Caldwell Lace-Up Dress Shoe-NEW WITH DEFECT
Cole Haan Mens Shoes $168 NEW Caldwell Burgundy Leather Oxford 9.5 D
This is the "Caldwell" style in burgundy high gloss leather. This is an excellent quality, stylish blucher oxford featuring a premium leather upper with 4 eyelet lacing, leather lining, cushioned leather full length footbed & a leather sole.
Cole Haan Mens 08330 Caldwell Black Leather Cap Toe Oxfords Shoes US 8.5 D
Light creasing on the toe area (photo 3). some marks on the ankle area. (photo 4-5).
Cole Haan Caldwell Cap Toe Patent Leather Dress Formal Oxfords Men's US 9.5D
ITEM: Cole Haan Caldwell Cap Toe Patent Leather Dress Formal Oxfords. MEASUREMENTS:The outer sole measures 11 3/4" in length from heel to toe, and 4 1/4" in width at the widest point. SIZE: Men's US 9.5D.
Cole Haan Mens 'Caldwell' Lace Up Cap Toe Oxford. Style Name: Caldwell. Lace Up Front Closure With Five Blind Eyelets. Closed Rounded Cap Toe. Department: Mens. Materials: Leather Upper, Leather Lining, Leather Sole.
Was: Previous priceAU $214.89
Cole Haan Mens 'Caldwell' Lace Up Cap Toe Oxford. Style Name: Caldwell. Closed Rounded Cap Toe. Lace Up Front Closure With Five Eyelets. Department: Mens. Materials: Leather Upper/Lining/Sole, Leather/Rubber Heel.
Cole Haan Men's Caldwell Lace-Up Derby Shoes
Men's Cole Haan Caldwell 08330 Size 10.5D Black Leather Cap Toe Dress Oxfords G7
Cole Haan Mens Caldwell Black Patent Leather Dress Oxfords Shoes 08330 Size 8.5
Style #08330. Finest, hand-burnished leather upper. Fully leather lined. Exclusive leather covered memory flex insole system. Wheeled leather welt. Waxed and buffed leather outsole with combination leather/rubber heel.
Stacy Adams Men's Caldwell Leather Oxford Lace Up Dress Shoes Congac 24904
Cole Haan 'Caldwell' Men's Dress Shoe -Size 10- Medium
Cole Haan 'Caldwell' Men's Dress Shoe. Dress up for a special occasion with the Caldwell cap toe oxford from Cole Haan. This handsome shiny leather shoe is perfect for a black tie affair. Medium Width- 4".
Cole Haan Men's 9 D Caldwell Black Cap Toe Oxford Dress Shoes Leather
You are purchasing a pair of Cole Haan Men's 9 D Caldwell Black Cap Toe Oxford Dress Shoes Leather Made in Maine. Condition : Most used shoes, boots, sandals, etc will typically have wear such as scuffs, scratches.
Cole Haan 08330 Caldwell Men Black Patent Leather Oxford Shoe 13D Pre Owned #AH
Size - 13D (Medium). Material - Patent Leather. Color - Black.
Cole Haan Caldwell Burgundy Leather Derby Oxford Mens Dress Shoes SZ 8.5
Fully leather lined.Wheeled leather welt.Waxed and buffed leather outsole with combination leather and rubber heel. Some shoes listed are new without box and some shoes are slightly used and are in excellent condition.
Cole Haan Mens Caldwell Cap Toe Oxford Dress Shoes - Size 10.5 D, Black
From Heel to Toe - 12". Heel - 1".
Cole Haan Caldwell Burgundy Leather Derby Oxford Mens Dress Shoes SZ 10.5
Men's Cole Haan "Caldwell" Lace Up Dress Shoes Burgundy Leather 10.5 D
This is a very nice pair of men's Cole Haan "Caldwell" Lace up dress shoes in Burgundy leather size 10.5 M in excellent condition.
Cole Haan "Caldwell" Black Lace Up ,. Oxfords Size 11M
Cole Haan black leather dress shoes Oxford. Size 11M. Very nice condition. Gently worn.
Cole Haan Burgundy Leather Men's Lace Up Dress Cap Toe Oxford Size 11 D
This comes from a non-smoking home.
Cole Hahn Men’s 10.5 D CALDWELL Burgundy Leather Cap Toe Dress Oxfords Shoes
Cole Hahn CALDWELL Burgundy Leather Cap Toe Dress Oxfords Shoes Men’s Size 10.5 D. Color: Burgundy ~ Tan interior. Condition: Quality shoes with signs of significant wear—wrinkles/creases to parts of the leather, slight discolorations, some scuffs and worn soles.
Cole Haan City Caldwell Burgundy Leather Cap Toe Derby Oxfords Shoes Mens 14 D
Cole Haan City. "Caldwell". Dress Casual Derby Oxfords Lace Up Shoes. Cap Toe. Burgundy Leather.
Stacy Adams 24904 Caldwell Dress Shoes-Men's size 9M Brown
US: 9M. Shoes have wear on the inner and outer soles. Minor scuffing. Width: 4.5".
New LEATHER ; COLE HAAN Caldwell mens size 9.5 lace-up Black Dress Oxfords
New LEATHER ; COLE HAAN Caldwell mens size 9 lace-up Burgundy Dress Oxfords
The color is burgundy, aka: cordovan.
CaldwellFilter Applied

value: This website is an American multinational e-commerce corporation based in San Jose, California, that facilitates consumer-to-consumer and business-to-consumer sales through its website.


text: _.ok=function(){this.R=[];this.H=[]};_.f=_.ok.prototype;_.f.$e=function(){return this.R.length+this.H.length};_.f.ze=function(){return _.Fb(this.R)&&_.Fb(this.H)};_.f.clear=function(){this.R=[];this.H=[]};_.f.contains=function(a){return _.Eb(this.R,a)||_.Eb(this.H,a)};_.f.remove=function(a){var b=this.R;var c=(0,_.vb)(b,a);0<=c?(_.Hb(b,c),b=!0):b=!1;return b||_.Ib(this.H,a)}; _.f.Ie=function(){for(var a=[],b=this.R.length-1;0<=b;--b)a.push(this.R[b]);var c=this.H.length;for(b=0;bTravis Smith - Google+Press question mark to see available shortcut keysHomeCollectionsJoin Google+Send FeedbackHelpRegionPrivacy Policy - Terms of Service - Maps Terms©2017 GoogleSearchSign inAboutSearchSign inTravis Smith345 followers345 followersAboutTravis's postsLooks like you've reached the endLooks like you've reached the endUnable to load more. RetryWait while more posts are being loaded

value: This website .